| Product Code: ETC5306089 | Publication Date: Nov 2023 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The import shipments of pneumonia vaccine to Latvia in 2024 continued to be dominated by key players such as Metropolitan France, Germany, Lithuania, Poland, and the USA. Despite a high concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market experienced significant growth with a compound annual growth rate (CAGR) of 43.42% from 2020 to 2024. However, there was a notable decline in the growth rate from 2023 to 2024 at -57.01%, suggesting potential shifts in market dynamics or regulatory changes impacting the import of pneumonia vaccines to Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Pneumonia Vaccine Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Pneumonia Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Latvia Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Latvia Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2022 & 2032F |
3.6 Latvia Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.7 Latvia Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2022 & 2032F |
3.8 Latvia Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Latvia Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumonia |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Rising prevalence of pneumonia cases in Latvia |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 High cost associated with pneumonia vaccines |
4.3.3 Lack of education and understanding about the benefits of vaccination |
5 Latvia Pneumonia Vaccine Market Trends |
6 Latvia Pneumonia Vaccine Market Segmentations |
6.1 Latvia Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2022 - 2032F |
6.1.3 Latvia Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2022 - 2032F |
6.2 Latvia Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Latvia Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2022 - 2032F |
6.2.3 Latvia Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2022 - 2032F |
6.2.4 Latvia Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2022 - 2032F |
6.3 Latvia Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Latvia Pneumonia Vaccine Market Revenues & Volume, By Public, 2022 - 2032F |
6.3.3 Latvia Pneumonia Vaccine Market Revenues & Volume, By Private, 2022 - 2032F |
6.4 Latvia Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Latvia Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2022 - 2032F |
6.4.3 Latvia Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2022 - 2032F |
6.4.4 Latvia Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2022 - 2032F |
7 Latvia Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Latvia Pneumonia Vaccine Market Export to Major Countries |
7.2 Latvia Pneumonia Vaccine Market Imports from Major Countries |
8 Latvia Pneumonia Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates in Latvia |
8.2 Number of government-funded vaccination campaigns |
8.3 Rate of pneumonia cases reported in Latvia per year |
9 Latvia Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Latvia Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2022 & 2032F |
9.2 Latvia Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.3 Latvia Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2022 & 2032F |
9.4 Latvia Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Latvia Pneumonia Vaccine Market - Competitive Landscape |
10.1 Latvia Pneumonia Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Latvia Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here